Powerful Medical
3. October 2024

Powerful Medical’s Global Presence: A Month of Innovation and Collaboration

September has been an exhilarating month for the Powerful Medical team as we connected with global thought leaders, innovators, and clinicians at key international events. Our mission to push the boundaries of modern medicine with AI-driven solutions was at the forefront of these engagements. From Boston to Lisbon, Madrid to Karlsruhe, our team made a significant impact at every stop. Here’s a closer look at our participation in these pivotal events.

LSX Boston and LSI 24 Lisbon: Revealing Our New PMcardio for Organizations Platform

Our team began the month with CEO Martin Herman representing Powerful Medical at LSX Boston and LSI 24 in Lisbon, where he unveiled our brand-new PMcardio for Organizations platform. In his impactful presentations, Martin showcased how our innovative platform is revolutionizing the chest pain patient pathway with AI, significantly improving clinical outcomes.

Powerful Medical’s Global Presence: A Month of Innovation and Collaboration

He presented our latest clinical validation results, which demonstrated a 13-hour reduction in door-to-balloon time for heart attack patients and a 67% decrease in false-positive cath-lab activations. These impressive results highlight the powerful role of AI in enhancing cardiovascular care and streamlining patient management across entire health systems.

Google’s “Health in the AI Era” Event in Madrid: Driving AI Innovation in Cardiology

In Madrid, both Martin Herman and COO Felix Bauer took part in Google for Startups’ “Health in the AI Era” event. Felix delivered a standout presentation on the future of AI in healthcare, emphasizing how AI-powered solutions like PMcardio are revolutionizing clinical decision-making and improving patient care.

Powerful Medical’s Global Presence: A Month of Innovation and Collaboration
Powerful Medical’s Global Presence: A Month of Innovation and Collaboration

Currently supporting over 45,000 clinicians, PMcardio is helping streamline cardiovascular treatment and reduce diagnostic times for acute myocardial infarction patients. The event also provided an opportunity to reconnect with our valued investor, Inaki Berenguer from LifeX Ventures, further strengthening our vision of transforming healthcare with the support of our valued partners.

Computing in Cardiology (CinC) 2024 in Karlsruhe: Advancing AI-Powered Cardiology Solutions

While Martin and Felix were in Lisbon and Madrid, our Head of AI, Adam Rafajdus, and Head of Clinical Partnerships, Michal Martonak, attended Computing in Cardiology 2024 (CinC) in Karlsruhe, Germany. At this premier event for cutting-edge cardiac technology, Adam and Michal engaged with health-tech professionals, clinicians, and academics to discuss the latest advancements in AI-driven cardiology solutions.

Powerful Medical’s Global Presence: A Month of Innovation and Collaboration

They highlighted how Powerful Medical’s innovations are pushing the boundaries of modern medicine, particularly through our AI-powered chest pain patient pathway, which has been proven to significantly improve early detection and intervention for heart attack patients. The event showcased the growing role of AI in analyzing complex patient data and accelerating the time to treatment in emergency settings.

The Road Ahead: AI for Better Cardiovascular Care Worldwide


Our participation in these global events not only allowed us to showcase our latest AI and product advancements but also reaffirmed the value of collaboration in driving healthcare innovation. Each event underscored the importance of AI in shaping the future of healthcare, and we are proud to be at the forefront of this transformation.

At Powerful Medical, we remain committed to delivering solutions that empower clinicians, improve patient outcomes, and drive efficiencies in healthcare systems worldwide. As we continue to build on the insights gained from these events, we are excited to push the boundaries of what’s possible with AI-driven cardiovascular care.

Stay tuned as we continue our journey of innovation and collaboration across the globe!

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

STEMI-mimics-cover

STEMI Mimics: Spot Subtle Impostors of Myocardial Infarction

The diagnosis of ST-Elevation Myocardial Infarction (STEMI) is a time-sensitive clinical challenge with critical implications for morbidity and mortality. However, identifying a true STEMI based solely on ECG changes is not always straightforward, as a number of other conditions, collectively termed STEMI mimics.

Launch of the Post-ROSC ECG Analysis using AI (PEACE AI) Validation Study

We are excited to announce the latest multi-center validation study of our AI platform, PMcardio. This study evaluates the effectiveness of our AI model (Queen of Hearts) in detecting Occlusive Myocardial Infarction (OMI) using 12-lead ECGs recorded in patients who have been resuscitated after an out-of-hospital cardiac arrest (OHCA).

Join 25,000 healthcare professionals who are already taking advantage of AI